|
HY-W003972-500mg
|
MedChemexpress LLC
|
2,6-Dimethoxyphenol [CAS 91-10-1]
|
|
|
|
|
HY-153006-10mg
|
MedChemexpress LLC
|
2,7-Dichlorodihydrofluorescein [CAS 106070-31-9]
|
|
|
|
|
HY-153006-25mg
|
MedChemexpress LLC
|
2,7-Dichlorodihydrofluorescein [CAS 106070-31-9]
|
|
|
|
|
HY-153006-5mg
|
MedChemexpress LLC
|
2,7-Dichlorodihydrofluorescein [CAS 106070-31-9]
|
|
|
|
|
HY-153006-50mg
|
MedChemexpress LLC
|
2,7-Dichlorodihydrofluorescein [CAS 106070-31-9]
|
|
|
|
|
HY-W040143-1g
|
MedChemexpress LLC
|
2',7'-Dichlorofluorescein [CAS 76-54-0]
|
|
Cancer-programmed cell death
|
|
|
HY-W040143-5g
|
MedChemexpress LLC
|
2',7'-Dichlorofluorescein [CAS 76-54-0]
|
|
Cancer-programmed cell death
|
|
|
HY-B1306S-1mg
|
MedChemexpress LLC
|
4-Aminohippuric acid-d4 [CAS 1219805-41-0]
|
|
|
|
|
HY-W034953-100mg
|
MedChemexpress LLC
|
Bathocuproine disulfonate (disodium) [CAS 52698-84-7]
|
|
|
|
|
HY-W034953-250mg
|
MedChemexpress LLC
|
Bathocuproine disulfonate (disodium) [CAS 52698-84-7]
|
|
|
|
|
HY-D0006-1g
|
MedChemexpress LLC
|
Bathophenanthroline [CAS 1662-01-7]
|
|
|
|
|
HY-D0006-500mg
|
MedChemexpress LLC
|
Bathophenanthroline [CAS 1662-01-7]
|
|
|
|
|
HY-114353-1mg
|
MedChemexpress LLC
|
BDP FL azide [CAS 1379771-95-5]
|
|
|
|
|
HY-114353-5mg
|
MedChemexpress LLC
|
BDP FL azide [CAS 1379771-95-5]
|
|
|
|
|
HY-D1094-1mg
|
MedChemexpress LLC
|
Carboxy-SNARF 1 (5/6-mixture) [CAS 126208-12-6]
|
|
|
|
|
HY-D1094-5mg
|
MedChemexpress LLC
|
Carboxy-SNARF 1 (5/6-mixture) [CAS 126208-12-6]
|
|
|
|
|
HY-D0032-100ug
|
MedChemexpress LLC
|
DAF-2DA [CAS 205391-02-2]
|
|
|
|
|
HY-D0032-250ug
|
MedChemexpress LLC
|
DAF-2DA [CAS 205391-02-2]
|
|
|
|
|
HY-D0032-500ug
|
MedChemexpress LLC
|
DAF-2DA [CAS 205391-02-2]
|
|
|
|
|
HY-100302-1mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-10mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-100mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-25mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-5mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-50mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
